Background. The impact of influenza vaccination on major cause-specific hospitalization and the duration of hospital stay is rarely reported. Our purpose was to study the effect of vaccine efficacy on major disease-specific hospitalization and the duration of hospital stays among elderly persons.
Influenza is associated with high rates of morbidity and mortality worldwide. In the United States alone, influenza causes an average of 114,000 hospital admissions each year, 43% of which occur among the elderly population (age, у65 years) [1] . Although influenza vaccination has been suggested for the elderly population in several developed countries, and although coverage has increased, it is still underimplemented in many countries or is recommended only for so-called "highrisk" groups because of doubts about its efficacy [2, 3] .
It is well established that influenza vaccination can reduce the need for hospitalization for pneumonia and influenza [4] [5] [6] [7] , chronic lung disease [4] [5] [6] 8] , diabetes [9] , and congestive heart failure and heart diseases [4, 5, 7, 10] , as well as for hospitalization of persons in high-risk groups [1] . Vaccine efficacy for reducing other major-cause hospitalization rates or the hospitalization rates among low-risk groups, however, is unknown.
Because influenza vaccination decreases the severity of illness, it can reduce the duration of antibiotic use during hospitalization [11] and shorten the number of days that the patient is febrile [12] . Its effect on the length of hospital stays, however, is not yet known. Our purpose was to analyze the efficacy of influenza vaccination on major cause-specific hospitalization and its effect on the length of hospital stays, stratified by risk status.
SUBJECTS AND METHODS
Background description. Kaohsiung County, in southern Taiwan, has 1.21 million registered residents. At the end of 2000, there were 102,698 registered elderly residents, 80%-90% of whom actually lived in the county, according to unpublished estimates by the Kaohsiung County Civic Office and Police Department. In Taiwan, ∼96% of the residents are covered by National Health Insurance (NHI), a government-run, singlepayer national health insurance plan initiated in 1995 [13] . At most, therefore, there were an estimated 88,731 (102,698 ϫ 0.96 ϫ 0.9) elderly persons who were living in the county and who participated in the NHI program. In Taiwan, influenza vaccination began in October 1998 for the high-risk elderly population, which is defined by the Department of Health (DOH) as those with a history of hospitalization since the establishment of the NHI in 1995 or as those living in longterm care facilities. The low-risk elderly population included persons who were not classified as high-risk individuals. Because high-risk elderly persons may be more limited in movement than low-risk elderly persons, the actual number of highrisk residents in the county was estimated to be 21,347, the same as reported by the DOH. The number of low-risk elderly persons was estimated to be 67,384 ( ), because 88,731 Ϫ 21,347 they were more likely to have moved out or traveled out of the county during the follow-up period.
In this study, vaccinations were paid for by the DOH and given without charge to elderly persons registered in Kaohsiung County In September 2000, each high-risk elderly resident received a notification letter from the DOH about the vaccination program. This letter entitled them to undergo influenza vaccination starting on 1 October at any contracted clinic or hospital with a supervising internist or family physician and at each township's community health center. There were 28 hospitals, 90 clinics, and 27 township community health centers in the county providing vaccinations during this period. Lowrisk participants were informed of the vaccination program by the mass media and health care systems, and they came for the vaccination on their own volition. The vaccination program ran from 1 October through 31 December 2000. By the end of this 3-month program, 36,520 elderly residents had received influenza vaccine, and 35,637 registered participants (97.6% of the elderly persons who had been vaccinated) were alive and were enrolled in our 6-month study program. One facet was the demographic data of the vaccinated elderly persons from the DOH. The data included all of the registered elderly persons in the county who had received a vaccination in Kaohsiung County or in other places in Taiwan. The second facet was the data for all hospitalized elderly persons from the Kao-Ping Branch of the NHI. These data included demographic information, length of hospital stay, and first major diagnosis, which was made and provided by the admitting physician of each hospitalized patient in each hospital. Each hospitalization event was recorded, so any participant might have had 11 hospitalization event. The third facet was the demographic data for all 102,698 registered elderly persons in Kaohsiung County. We linked these computerized data sets to conduct a statistical analysis. The study was approved by the Research Committee of the Kaohsiung County Bureau of Health.
Outcome evaluation. Hospitalization causes were classified according to The International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) [14] . Major diseases include neoplasms (ICD-9-CM code, 140-239); diabetes mellitus (DM; 250.00-250.91); heart disease (401-405, 410-414, and 420-429); lung disease; cerebrovascular disease (i.e., stroke; 430-438); peptic ulcers (531-534); chronic liver disease and cirrhosis (i.e., liver disease; 571); nephritis, renal syndrome, and nephrosis (i.e., renal disease; 580-589); and injury and poisoning (800-999). Lung diseases include pneumonia and influenza (480-487), chronic obstructive pulmonary disease (COPD; 490-496), and other diseases of the respiratory system (510-519).
Statistical analysis. Statistical analyses included univariate analysis for incidence rate ratio (IRR) and efficacy ( ) 1 Ϫ IRR between vaccinated and unvaccinated hospitalized study participants. Multivariate logistic regression analysis was used to determine the independent factor for all-cause hospitalization. Student's t test was used to determine the mean difference of the length of hospitalization. Multiple linear regression analysis was performed to determine the risk factor or preventive factor for the length of hospitalization for all causes and for lung disease. Propensity scores in multivariate logistic regression analysis were determined using SAS software (SAS Institute), and other analyses were performed using Stata software (Stata) [15] . Statistical significance was set at . P ! .05
RESULTS

Demographic data for influenza vaccination.
The total rate of influenza vaccination for the elderly was 0.35. The rate was 0.58 for the high-risk elderly population; 0.29 for the low-risk population; 0.35 for men, women, and persons aged 65-74 years; and 0.34 for those aged у75 years old.
Hospitalization rate and vaccine efficacy, stratified by risk status and vaccination status. Hospitalization rates for the high-risk elderly population were 31.8% for vaccinated individuals and 39.7% for unvaccinated individuals. For low-risk subjects, the rates were 12.1% and 15.7%. High-risk subjects had a hospitalization rate 2.4 times higher than that for lowrisk subjects (IRR, 2.4; 95% CI, 2.4-2.5). In both high-risk and low-risk groups, the efficacy of vaccination for reducing hospitalization rates was significant ( ) for all causes (20% P ! .05 vs. 23%), lung disease (22% vs. 25%), liver diseases (47% vs. 51%), renal disease (35% vs. 56%), congestive heart failure (43% vs. 32%), pneumonia and influenza (31% vs. 34%), and other diseases of the respiratory system (60% vs. 49%). It was also significant ( ) for stroke (36%), DM (28%), hyper-P ! .05 tension (37%), neoplasms (22%), and injury and poisoning (24%) in the low-risk group and for peptic ulcer (18%) in the high-risk group (table 1) .
Multivariate logistic regression for all-cause hospitalization. Multivariate logistic regression analysis for all-cause hospitalization using backward elimination, which included the variables sex, age, risk status, and vaccination status, showed that influenza vaccination was significantly associated with lower risk (adjusted OR, 0.89; 95% CI, 0.86-0.92), but high-risk status was strongly associated with increasing risk (adjusted OR, 3.69; 95% CI, 3.56-3.82).
Mean duration and mean difference in duration of hospital stay. Comparing the mean length and mean difference in duration of hospitalization showed that women, younger elderly persons (i.e., those aged 65-74 years), vaccinated subjects, and low-risk elderly individuals had shorter durations of hos- Mean duration and mean difference in duration of hospital stays, stratified by vaccination and risk status. Vaccinated subjects in both groups in our study had shorter durations of hospitalization for all causes (high-risk group: mean difference, 3.6 days [95% CI, 3.1-4.1 days]; low-risk group: mean difference, 1.5 days [95% CI, 1.04-1.9 days]) and COPD. Unvaccinated high-risk elderly patients had longer durations of hospitalization than did vaccinated high-risk elderly subjects for diabetes mellitus (mean difference, 2.9 days; 95% CI, 0.9-5.0 days), pneumonia and influenza (mean difference, 4.2 days; 95% CI, 2.4-6.1 days), and other diseases of the respiratory system (mean difference, 18.4 days; 95% CI, 11.6-25.2 days). Unvaccinated low-risk elderly persons who were hospitalized for neoplasms, however, had shorter durations of hospitalization than did vaccinated low-risk elderly persons (table 3) . No significant difference in the mean length of hospitalization was found for vaccinated or unvaccinated high-risk or low-risk elderly persons with peptic ulcer, chronic liver disease or cirrhosis, renal disease, or injury or poisoning (data not shown).
Multiple linear regression analysis of length of hospital stay. Multiple linear regression analysis of the length of hospitalization for all-cause hospitalized elderly persons showed that male sex, older age, and high-risk status increased the length of hospitalization, but that being vaccinated decreased the length (coefficient, Ϫ2.4 days; 95% CI, Ϫ2.7 to Ϫ2.1 days). For persons with lung diseases, being male and vaccinated significantly reduced the duration of hospitalization (coefficient, Ϫ4.9 days; 95% CI, Ϫ6.0 to Ϫ3.8 days), but high-risk status and older age increased the length (table 4) .
DISCUSSION
This observational population cohort study demonstrated that influenza vaccination reduced the rate of all-cause hospitalization. It not only reduced hospitalization rates for lung diseases, but it also reduced the rates for other common diseases, such as stroke, congestive heart failure, hypertension, diabetes mellitus, renal disease, and chronic liver disease and cirrhosis. The finding of reduced hospitalization rates for pneumonia, cardiac diseases, and stroke is consistent with the findings of a recent study with a large sample size [7] . Moreover, vaccine efficacy for other common diseases, such as stroke, other respiratory system diseases, and chronic renal disease in the lowrisk elderly population might be greater than the efficacy for pneumonia. Second, vaccination shortened the average length of hospitalization by 2.4 days for all causes and by 4.9 days for lung diseases. Third, risk status is an important factor for determining hospitalization rates and length of hospital stays. High-risk elderly persons had a ∼3.7-fold greater hospitalization rate and a 1.7-days longer hospital stay than did low-risk elderly persons, but vaccination shortened the length of hospital stay more for high-risk elderly individuals (by 3.6 days) than for low-risk elderly individuals (by 1.5 days).
Vaccine efficacy and reduction of hospitalization rates. Our study shows that overall vaccine efficacy in the low-risk elderly population was not less than that in the high-risk elderly population (23% vs. 20%); therefore, the total impact of vaccination on the low-risk group was probably much greater when measured in the total reduction of the utilization of health care resources, because there were у3 times as many persons in our low-risk group than in our high-risk group. Lowering major cause-specific hospitalization rates in the low-risk elderly population might indicate the reduction of the incidence of stroke, pneumonia, congestive heart failure, other respiratory system diseases, and injury and the prevention of subsequent longterm complications and health care burdens, because low-risk participants were defined as not having a history of hospitalization. In the elderly population, hospitalization often results in an irreversible decline in functional status and quality of life, and it increases the mortality rate [16] . In addition, elderly persons with a history of hospitalization might consequently experience an increase in the number of hospitalizations in the future, as occurred in the high-risk elderly population in the present study. The evidence from this population study might mitigate doubts about the efficacy of influenza vaccination, especially for the low-risk elderly population. Additional studies are needed to elucidate the possibilities.
Shortening the duration of hospitalization. In the current study, vaccination significantly shortened the duration of allcause hospitalization in both the high-risk and the low-risk groups. The greatest decrease occurred for hospitalization caused by lung diseases, especially pneumonia and other diseases of the respiratory system. Shortening hospital stays might be related to amelioration in illness severity and its complications after influenza vaccination [17] . Shortening hospital stays will produce a great economic impact by increasing the availability of hospital beds, decreasing the length of waiting lists for hospital admission, and reducing the use of health care resources. Its benefits might greatly outweigh the costs of annual vaccination. Whether the decrease in the length of hospitalization after vaccination might indicate that vaccination would lower mortality rates merits additional study. Possible mechanisms for vaccine efficacy. Because ∼70% of elderly persons have 11 chronic disease [18] , vaccine efficacy might be explained as follows. First, the systemic inflammation caused by influenza might alter endothelial function, inhibit vasodilatation, cause atheroma instability, and subsequently initiate further progression of atherosclerosis [19] , congestive heart failure [20] , and stroke [21] or exacerbate a chronic renal condition [22, 23] . The possible mechanism of systemic inflammation might be most influential, because most elderly persons have atherosclerosis. Stress and high fever due to influenza may cause hyperglycemia and adversely affect fluid balance and the immune function [24] . Stress and high fever might also be important contributing factors to the exacerbation of chronic liver disease [25, 26] . Second, complications arising from the treatment of related signs and symptoms of influenza, such as from the use of nonsteroid anti-inflammatory drugs for fever or myalgia, might result in peptic ulcer and upper gastrointestinal bleeding [27] , renal toxicity [28] , or acute liver failure [26] . Adverse effects associated with the treatment of influenza or with influenza itself might increase falls or traffic accidents because of declining judgmental abilities and major physical functions, such as mobility, balance, and muscle strength [29] . Third, complications might result from poor compliance in the control of existing diseases, such as hypertension and diabetes mellitus, which might exacerbate underlying medical conditions and increase the number of hospitalizations for congestive heart failure, stroke, diabetes mellitus [1, 24, 30] , and renal diseases [23] . Except for pneumonia, most of the conditions worsened by influenza might occur several days, weeks, or months after influenza virus infection, thereby creating a latency period between the onset of influenza and hospitalization for its consequences. Therefore, influenza has not generally been listed as a cause of hospitalization.
Limitations of the study. There were some limitations to this study. First, although all subjects came for a vaccination on their own volition, and although we used multivariate logistic regression analysis to examine the association between vaccination and hospitalization, selection bias might have occurred. The decision to receive vaccination might have been influenced by health status, socioeconomic status, the accessibility of health care, and the attitude of health care organizations and providers [31] , which were not analyzed in the current study. Second, the reported incidence of hospitalization in the present study was estimated, because 110% of the registered elderly persons-unvaccinated and low-risk elderly persons, in particular-did not reside in this county, and only the hospitalizations in the regions covered by the Kao-Ping Branch of the NHI were included. Therefore, the vaccine efficacy and the incidence of hospitalization for high-risk and low-risk elderly persons shown in table 2 and the OR for the vaccination status in multivariate logistic regression might have been underestimated, because the total number of elderly residents was the denominator, and at least 10%-20% of the registered elderly persons were not living in the county, or their hospitalizations were not in the regions covered by the Kao-Ping Branch of the NHI. Third, although this was a multiple-hospital study covered under the auspices of a single national health insurance program, the hospitalization criteria and the length of hospitalization might have been different for each hospital. These limitations might have affected the outcome evaluation in the current study.
In conclusion, influenza vaccination reduced the rate of hospitalization not only for lung diseases, but also for all causes and other common diseases in both high-risk and low-risk elderly. The impact of reducing the rate of hospitalization in the low-risk elderly population may be greater than is immediately apparent because of the effect of hospitalization on longterm complications of influenza. Influenza vaccination also shortened the length of hospital stays, especially for hospitalization for lung diseases. Shortening the duration of hospital stays may greatly reduce the use of health care resources and the length of waiting lists for hospital admission. This indicates that the influence of influenza vaccination of the elderly population may be broader than was previously known, with regard to disease-specific hospitalization rates and shortening hospital stays.
